New updates on global COVID-19 vaccines! On November 18, U.S. Secretary of Health and Human Services Alex Azar stated that the U.S. will have 40 million doses of COVID-19 vaccine next month. The vaccine will be administered to U.S. residents in phases, with all vaccinations expected to be completed by April of next year, free of charge.
It is reported that two safe and effective vaccines have already been approved by the FDA and are ready for distribution and administration within a few weeks. States and territories will begin distributing the vaccine within 24 hours of receiving regulatory authorization. According to this plan, the U.S. can complete the vaccination of all residents by next summer, and once the vaccination rate exceeds 80%, herd immunity can be declared.
How to get vaccinated? Three-phase vaccination work
The first group to be vaccinated includes residents and staff of nursing homes and assisted living facilities, especially those with underlying health conditions (including adults with chronic diseases such as hypertension and diabetes) and the elderly over 65.
The second group consists of hospital medical personnel, with vaccinations for this group to be completed by the end of January next year.
The third group will be open to all Americans, and it is expected that sufficient vaccines will be available for all Americans by the end of March to early April next year.
How many doses are needed? What is the cost?
To be fully effective, the COVID-19 vaccine requires two doses, spaced about 3 weeks apart. Both doses must be from the same manufacturer. When receiving the vaccine, the healthcare provider will register a vaccination record card, which details the vaccine manufacturer and lot number, and will also indicate the date for the second dose.
According to the bill previously signed by President Trump, all U.S. residents will receive the COVID-19 vaccine for free.
Are there enough vaccines?
The Trump administration has signed a $1.95 billion contract with Pfizer to purchase 100 million doses of the COVID-19 vaccine, enough to vaccinate 50 million people, with the option to purchase an additional 500 million doses.
In addition, the Trump administration has signed a $1.5 billion contract with Moderna to purchase 100 million doses of the vaccine, with the option to purchase an additional 400 million doses.
In December, the two companies will be able to provide 40 million doses of the vaccine, enough for 20 million people.
Where to get vaccinated?
The federal government will allocate vaccine supplies to the states, and the states will then be responsible for managing vaccine distribution. Each jurisdiction will decide for itself how to distribute the vaccine to hospitals, pharmacies, and universities.
In the early stages, the Centers for Disease Control and Prevention (CDC) recommends that states administer vaccines in large hospitals and health systems, pharmacies, and clinics. In addition, the CDC has reached an agreement with two major U.S. pharmacy chains—CVS and Walgreens—to allow vaccinations at these two pharmacies.
Currently, institutions that have been approved to provide vaccination services include: Walgreens, CVS, Walmart, Rite Aid, Kroger Co, Albertsons, and Costco. This means that the aforementioned supermarkets and pharmacies can provide COVID-19 vaccinations.
As we know, the United States has a sound social welfare and medical security system, and its medical technology is quite advanced. The announcement of this COVID-19 vaccination plan is undoubtedly a major breakthrough.
In recent years, the United States has attracted many people due to its various advantages. Among them, the U.S. EB-5 investment immigration is an excellent way, with relaxed application requirements, no language requirements, and no immigration jail. Most importantly, one person applies, the whole family immigrates, enjoys the generous benefits of the United States, and children enjoy world-class education.
Currently, the U.S. Citizenship and Immigration Services (USCIS) continues to receive and process immigration applications as usual. You should lock in high-quality projects early based on your own situation, "prepare early, apply early, queue early, and benefit early"!
For those who are interested in immigrating to the United States, the Yellowstone Club Phase II project, which is highly favored by investors, is the best choice to help investors successfully immigrate to the United States. As one of the few EB-5 projects on the market that complies with the new regulations for low-cost $900,000 immigration, this project combines many outstanding advantages such as dual approval from the immigration bureau, excess completion of employment, five-fold asset mortgage repayment, and transparent fund supervision, which greatly protects the interests of investors.
Ten Advantages of the Yellowstone Club Phase II EB-5 Project
1. Rural area EB-5 project, eligible for low-cost $900,000 immigration
2. The project has obtained both I-526 exemplar and individual approvals
3. Extremely high employment multiplier; construction has started, and the required employment has been completed in advance
4. Low EB-5 proportion, high equity investment proportion
5. Ultra-high value mortgage, with mortgage value up to 5 times the EB-5 loan amount
6. Strong brand appeal of Yellowstone Club, with over 1/2 of the apartments pre-sold
7. Named, operated, and managed by the well-known luxury hotel brand Montage
8. Developed and constructed by the experienced and powerful developer CrossHarbor
9. Successful experience of Yellowstone Club Phase I EB-5 project replicated
10. Professional EB-5 team oversight & the 3rd successful collaboration between Worldway and EB-5
For more details, please consult the Worldway service hotline: Mainland China: 400-138-2929; Hong Kong, China: (852) 2802 8798
Some materials in this article are from the Internet, and the copyright belongs to the original author. If there are any copyright issues, please contact the original author and us for deletion.